• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Xeris Biopharma Holdings, Inc. - Common Stock (NQ:XERS)

7.350 -0.500 (-6.37%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,801,599
Open 7.880
Bid (Size) 7.350 (600)
Ask (Size) 7.610 (100)
Prev. Close 7.850
Today's Range 7.260 - 7.946
52wk Range 3.140 - 10.08
Shares Outstanding N/A
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
January 02, 2026
From Xeris Biopharma Holdings, Inc.
Via Business Wire
News headline image
Why Xeris Biopharma Stock Zoomed 7% Higher on Wednesday ↗
December 31, 2025
One of the company's key drugs won't be challenged by a competing medication anytime soon. 
Via The Motley Fool

Performance

YTD
N/A
N/A
1 Month
+9.2%
+9.2%
3 Month
-10.4%
-10.4%
6 Month
+56.4%
+56.4%
1 Year
+112.4%
+112.4%

More News

Read More
The market is filled with gapping stocks in Wednesday's session. ↗
December 31, 2025
Via Chartmill
News headline image
Xeris Announces Notice of Allowance from U.S. Patent and Trademark Office for XP-8121 Patent Application
December 01, 2025
From Xeris Biopharma Holdings, Inc.
Via Business Wire
News headline image
Earnings Scheduled For November 6, 2025 ↗
November 06, 2025
Via Benzinga
News headline image
Earnings Scheduled For August 7, 2025 ↗
August 07, 2025
Via Benzinga
News headline image
Earnings Scheduled For May 8, 2025 ↗
May 08, 2025
Via Benzinga
News headline image
Xeris Biopharma (XERS) Q3 2025 Earnings Transcript ↗
November 06, 2025
Via The Motley Fool
News headline image
XERIS BIOPHARMA HOLDINGS INC (NASDAQ:XERS) Posts Record Q3 2025 Revenue but Misses Analyst Estimates ↗
November 06, 2025
Via Chartmill
News headline image
Xeris Biopharma Posts Record Financial Results for the Third Quarter 2025
November 06, 2025
From Xeris Biopharma Holdings, Inc.
Via Business Wire
News headline image
Xeris Biopharma to Report Third Quarter 2025 Financial Results on November 6, 2025
October 23, 2025
From Xeris Biopharma Holdings, Inc.
Via Business Wire
News headline image
Earnings Outlook For Xeris Biopharma Holdings ↗
May 07, 2025
Via Benzinga
News headline image
Xeris Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 03, 2025
From Xeris Biopharma Holdings, Inc.
Via Business Wire
News headline image
Xeris Announces Orange Book Listing of U.S. Patent for Recorlev®
August 25, 2025
From Xeris Biopharma Holdings, Inc.
Via Business Wire
News headline image
Xeris (XERS) Q2 Revenue Jumps 49% ↗
August 07, 2025
Via The Motley Fool
News headline image
Traders are paying attention to the gapping stocks in Thursday's session. ↗
August 07, 2025
Via Chartmill
News headline image
XERIS BIOPHARMA HOLDINGS INC (NASDAQ:XERS) Surges 12% After Q2 Earnings Beat and Raised Revenue Guidance ↗
August 07, 2025
Via Chartmill
Topics Earnings
News headline image
Xeris Biopharma Reports Record Financial Results for the Second Quarter 2025 and Raises Full Year Revenue Guidance
August 07, 2025
From Xeris Biopharma Holdings, Inc.
Via Business Wire
News headline image
Xeris Biopharma to Report Second Quarter 2025 Financial Results on August 7, 2025
July 31, 2025
From Xeris Biopharma Holdings, Inc.
Via Business Wire
News headline image
XERIS BIOPHARMA HOLDINGS INC (NASDAQ:XERS) – A Strong Growth Candidate Meeting Minervini’s Criteria ↗
July 07, 2025
Via Chartmill
News headline image
Xeris Unveils Strategy for Long-Term Growth and Value Creation at 2025 Analyst & Investor Day
June 03, 2025
From Xeris Biopharma Holdings, Inc.
Via Business Wire
News headline image
Xeris Announces Details for Analyst & Investor Day
May 20, 2025
From Xeris Biopharma Holdings, Inc.
Via Business Wire
News headline image
XERIS BIOPHARMA HOLDINGS INC (NASDAQ:XERS) – A High-Growth Stock Meeting Minervini’s Trend Template ↗
May 13, 2025
Via Chartmill
News headline image
Xeris Biopharma Reports Record First Quarter 2025 Financial Results
May 08, 2025
From Xeris Biopharma Holdings, Inc.
Via Business Wire
News headline image
Xeris Biopharma to Report First Quarter 2025 Financial Results on May 8, 2025
May 01, 2025
From Xeris Biopharma Holdings, Inc.
Via Business Wire

Frequently Asked Questions

Is Xeris Biopharma Holdings, Inc. - Common Stock publicly traded?
Yes, Xeris Biopharma Holdings, Inc. - Common Stock is publicly traded.
What exchange does Xeris Biopharma Holdings, Inc. - Common Stock trade on?
Xeris Biopharma Holdings, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Xeris Biopharma Holdings, Inc. - Common Stock?
The ticker symbol for Xeris Biopharma Holdings, Inc. - Common Stock is XERS on the Nasdaq Stock Market
What is the current price of Xeris Biopharma Holdings, Inc. - Common Stock?
The current price of Xeris Biopharma Holdings, Inc. - Common Stock is 7.350
When was Xeris Biopharma Holdings, Inc. - Common Stock last traded?
The last trade of Xeris Biopharma Holdings, Inc. - Common Stock was at 01/02/26 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap